1802489-60-6 Usage
Uses
Used in Pharmaceutical Industry:
6-Bromo-2-methoxypyridin-3-yl)methanol is used as a key intermediate in the synthesis of various pharmaceutical compounds. Its unique structure and functional groups make it a valuable building block for the development of new drugs and therapeutic agents.
Used in Pesticide Industry:
In the pesticide industry, 6-Bromo-2-methoxypyridin-3-yl)methanol is used as a starting material for the production of various agrochemicals. Its ability to form complex organic molecules makes it a useful component in the development of effective and targeted pesticides.
Used in Organic Synthesis:
6-Bromo-2-methoxypyridin-3-yl)methanol is used as a versatile building block in organic synthesis. Its presence of a bromine atom and methoxyl group allows for a wide range of chemical reactions and functionalizations, making it an important compound in the synthesis of various organic molecules.
Used in Chemical Research:
In the field of chemical research, 6-Bromo-2-methoxypyridin-3-yl)methanol is used as a valuable compound for studying various chemical reactions and mechanisms. Its unique structure and properties make it an interesting subject for research and development in the field of organic chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 1802489-60-6 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,8,0,2,4,8 and 9 respectively; the second part has 2 digits, 6 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1802489-60:
(9*1)+(8*8)+(7*0)+(6*2)+(5*4)+(4*8)+(3*9)+(2*6)+(1*0)=176
176 % 10 = 6
So 1802489-60-6 is a valid CAS Registry Number.
1802489-60-6Relevant academic research and scientific papers
PYRIDINONE DERIVATIVES AS SELECTIVE CYTOTOXIC AGENTS AGAINST HIV INFECTED CELLS
-
Page/Page column 48-49, (2020/12/07)
The present disclosure is directed to pyridinone derivatives of Formula I and their use for selectively killing HIV infected GAG-POL expressing cells without concomitant cytotoxicity to HIV nave cells, and for the treatment of infection by HIV, or for the treatment, prophylaxis or delay in the onset or progression of AIDS or AIDS Related Complex (ARC).
